Divalproex bulk supplier for pharma manufacturers

Divalproex 50 mg, 500 mg Suppliers & Bulk Manufacturers

Available Forms: Extended-Release Tablets

Available Strengths: 50 mg, 500 mg

Reference Brands: Depakote ER®(US)

Divalproex Extended-Release (Depakote ER) is a CNS medication used for epilepsy, bipolar disorder, and migraines. Available in 250 mg and 500 mg tablets in the US and EU, it supports once-daily dosing. A strategic neurotherapy product for B2B sourcing with global demand and regulatory compliance.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description: Divalproex Extended-Release (ER) is a widely prescribed anticonvulsant and mood stabilizer used to treat epilepsy, bipolar disorder, and migraine prophylaxis. This formulation ensures sustained drug release, offering once-daily dosing and improved patient compliance. Marketed in the US under Depakote ER and available across the EU in multiple generic and branded forms, Divalproex ER is manufactured in strengths of 250 mg and 500 mg. Its versatility in neuropsychiatric and neurological conditions makes it a key product for global pharmaceutical sourcing. Ideal for B2B buyers looking to expand in CNS therapeutics, Divalproex ER meets stringent regulatory and quality standards.

Divalproex — third party manufacturing & bulk supply

Divalproex 50 mg, 500 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Divalproex is supplied as Extended-Release Tablets — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Divalproex listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Divalproex →

Back to Listing

Frequently Asked Questions

Divalproex is listed as Extended-Release Tablets in 50 mg, 500 mg. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Divalproex is referenced against Depakote ER®(US). Reference brands are shown for identification only and remain the property of their respective trademark owners.